The company reported a strong 2025 profitability rebound, with EBIT up 36.56% to €6.48 million and net profit rising to €4.82 million from €1.82 million. EBIT margin expanded to 21.2% from 11.8%, although revenue fell 23.81% to €30.56 million due to renegotiated B2B agreements. Lower revenue was offset by reduced costs, supporting materially higher earnings.
This is a quality-over-growth inflection, not just a margin beat. The step-change in profitability despite a smaller top line implies management has pulled a structural lever on mix and pricing discipline rather than relying on cyclical demand, which usually compresses enterprise risk and improves free-cash-flow durability. The market should care more about whether the new partner economics are sticky than about the revenue decline itself; if those renegotiated terms reset the floor for future renewals, the earnings base could re-rate even with flattish or lower sales. Second-order winners are likely the company’s own capital allocators and any adjacent suppliers exposed to lower service intensity, because a leaner B2B model often reduces working-capital needs and can support higher cash conversion. The losers are competitors still defending volume with weak contract economics: they may need to match pricing concessions or add service spend, which can temporarily widen the margin gap in favor of this name. The subtle risk is that the profitability jump is partly a one-time contract reset; if partner churn or lower volumes bleed through over the next 2-4 quarters, the market may discount the margin rate as unsustainable. Catalyst timing is medium term. In the next 1-3 reporting periods, the key question is whether EBIT margin holds near the new level as the revenue base normalizes, or whether this becomes a classic ‘earnings peak after restructuring’ setup. If management can show stable cash generation and no material customer attrition, the stock often de-risks faster than peers because investors start valuing earnings quality over growth. The contrarian view is that consensus may be underestimating the signaling value of management’s willingness to sacrifice revenue for profitability. That is often a precursor to M&A optionality or at least a lower cost of capital, but it can also mask a business that is easier to optimize than to scale. The key tell will be whether 2026 guidance emphasizes volume recovery without margin giveback; if not, the move may have been fully priced as a restructuring pop.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.62